تقرير
Efficacy of empagliflozin for weight and glycemic control of a patient with Prader-Willi syndrome, systemic lymphedema and extreme obesity: a case report.
| العنوان: | Efficacy of empagliflozin for weight and glycemic control of a patient with Prader-Willi syndrome, systemic lymphedema and extreme obesity: a case report. |
|---|---|
| المؤلفون: | Farinha JB; Brazilian Company of Hospital Services, School Hospital at the Federal University of Pelotas, Dr Araújo Street 538, Pelotas, 96020360 Brazil., Weinert LS; Brazilian Company of Hospital Services, School Hospital at the Federal University of Pelotas, Dr Araújo Street 538, Pelotas, 96020360 Brazil., Costa LP; Brazilian Company of Hospital Services, School Hospital at the Federal University of Pelotas, Dr Araújo Street 538, Pelotas, 96020360 Brazil., Costa MZ; Brazilian Company of Hospital Services, School Hospital at the Federal University of Pelotas, Dr Araújo Street 538, Pelotas, 96020360 Brazil., de Peres PP; Brazilian Company of Hospital Services, School Hospital at the Federal University of Pelotas, Dr Araújo Street 538, Pelotas, 96020360 Brazil., Lorea CF; Brazilian Company of Hospital Services, School Hospital at the Federal University of Pelotas, Dr Araújo Street 538, Pelotas, 96020360 Brazil. |
| المصدر: | International journal of diabetes in developing countries [Int J Diabetes Dev Ctries] 2022 Oct; Vol. 42 (4), pp. 787-790. Date of Electronic Publication: 2022 Apr 27. |
| نوع المنشور: | Case Reports |
| اللغة: | English |
| بيانات الدورية: | Publisher: Springer India Country of Publication: India NLM ID: 101285656 Publication Model: Print-Electronic Cited Medium: Print ISSN: 0973-3930 (Print) Linking ISSN: 19983832 NLM ISO Abbreviation: Int J Diabetes Dev Ctries Subsets: PubMed not MEDLINE |
| أسماء مطبوعة: | Publication: 2011- : New Delhi : Springer India Original Publication: Bombay : Published ... on behalf of the Research Society for Study of Diabetes in India, 1999- |
| مستخلص: | A patient with Prader-Willi syndrome (PWS), extreme obesity and hyperglycemia had her body weight increased considerably for 6 months, even with exercise and diet programs. Treatment with metformin and empagliflozin (12.5 mg/day) induced a weight loss of 14 kg (-10.3%) for 6 months and the reduction of glycated hemoglobin A Competing Interests: Conflict of interestThe authors declare no competing interests. (© The Author(s), under exclusive licence to Research Society for Study of Diabetes in India 2022.) |
| فهرسة مساهمة: | Keywords: Case report; Exercise; Obesity, Morbid; Prader-Willi syndrome; SGLT-2 inhibitors |
| تواريخ الأحداث: | Date Created: 20220502 Latest Revision: 20221222 |
| رمز التحديث: | 20231215 |
| مُعرف محوري في PubMed: | PMC9042659 |
| DOI: | 10.1007/s13410-022-01076-1 |
| PMID: | 35495777 |
| قاعدة البيانات: | MEDLINE |
Find this article in full text from Springer Verlag. 
Full Text Finder | تدمد: | 0973-3930 |
|---|---|
| DOI: | 10.1007/s13410-022-01076-1 |